Procedures for Sample Acquisition and Distribution for The Human Brain Collection Core
NCT ID: NCT03092687
Last Updated: 2019-09-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
192 participants
OBSERVATIONAL
2017-03-21
2019-08-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The Human Brain Collection Core (HBCC) collects brain and other tissues. They get these from deceased people who may or may not have had psychiatric disorders. The next of kin gives permission for researchers to get the tissues. Researchers want to collect medical details of people whose brains are donated. They also want to use the donated tissue to study brain chemistry and structure. This could lead to better treatments for mental illness.
Objective:
To create a collection of human brain tissue to learn about the causes and mechanisms of mental disorders.
Eligibility:
People willing to donate their deceased relative s brain tissue. The deceased person could not have had any of the following:
Severe mental retardation
Long-lasting seizure disorder
Infections that affect the brain
Decomposition
Brain damage
Being on a respirator for more than 12 hours
Major sepsis
Serious renal or hepatic disease
Certain dementias and degenerative diseases
Design:
Medical Examiner s Offices will screen donors who have recently died. Some others will be screened by hospitals or funeral homes.
Participants will be the next of kin. They will give consent for HBCC to obtain brain tissue from the deceased person. The tissue will be frozen for future research.
Participants will have a 30-minute phone call. They will answer questions about the deceased person s medical and psychiatric conditions. They will answer questions about the person s use of medicines and drugs.
Participants will be contacted by a social worker. They will be asked for permission to access the deceased person s medical records.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Brain Tissue Collection for Neuropathological Studies
NCT00001260
Brain Imaging of Cognition Inn Schizophrenia and Depression
NCT04159662
Evaluation, Pathogenesis, and Outcome of Subjects With or Suspected Traumatic Brain Injury
NCT01132937
Brain Chemical Receptor Effects in Patients With Panic Disorder and Post-Traumatic Stress Disorder
NCT00025974
Electrophysiology and Blood Flow in Patients With Schizophrenia and Their Siblings
NCT00001921
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study Population: To be able to conduct this research, we obtain brain and other tissues from deceased individuals with and without psychiatric disorders.
Study Design: This protocol provides the ethical and scientific framework for tissue donations through referrals from Offices of the Chief Medical Examiners, hospitals or funeral homes. The next of kin are contacted to give permission for brain donation from the deceased. Once the tissue is obtained, it is frozen, catalogued and processed for distribution to other researchers and for in-house analysis. The HBCC dissects specific brain tissues based on request. All collaborations are subject to approval by an oversight committee. Currently, HBCC can leverage over 1,000 brains from a variety of psychiatric disorders and non-psychiatric subjects.
Outcome measures: Outcomes vary with specific collaborations, but include characterization of DNA, RNA, protein and other brain constituents that provide unique information at the molecular level. The data thus obtained are expected to provide new insights into brain physiology and the molecular pathology of psychiatric disorders, possibly leading to the identification of new therapeutic targets.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
psychiatric disorders
decedents with and without psychiatric use disorders
No interventions assigned to this group
substance disorders
decedents with and without substance use disorders
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
excluded from collection:
* Severe mental retardation.
* Well documented, long lasting seizure disorder.
* Infections known to affect the brain such as syphilis, tuberculosis, with the exception of HIV infection.
* The body is decomposed. We consider collecting the brain up to three days after death.
* There is obvious damage to the brain by closed head injury or other trauma (gunshot wound, fall, etc.).
* There are brain infarcts, hemorrhages, tumors, stroke, or other brain lesions that destroy the normal brain structure.
* The patient has been maintained on a respirator (ventilator) for more than 12 hours in the period immediately prior to death.
* Major sepsis.
* Serious renal or hepatic disease.
* Multiple sclerosis (MS), Alzheimer s disease and other dementias and degenerative diseases.
* Known infection with Hepatitis C
120 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of Mental Health (NIMH)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stefano Marenco, M.D.
Role: PRINCIPAL_INVESTIGATOR
National Institute of Mental Health (NIMH)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
National Institute of Mental Health (NIMH)
Bethesda, Maryland, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17-M-N073
Identifier Type: -
Identifier Source: secondary_id
999917073
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.